Canada Life
PASG icon

Canada Life’s Passage Bio PASG Stock Holding History

Canada Life’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-113
Closed -$8K – 2456
2022
Q1 		$8K Buy
113
+21
+23% +$1.73K ﹤0.01% 2450
2021
Q4 		$11K Buy
92
+19
+26% +$3.1K ﹤0.01% 2444
2021
Q3 		$15K Hold
73
– – ﹤0.01% 2478
2021
Q2 		$19K Hold
73
– – ﹤0.01% 2490
2021
Q1 		$25K Hold
73
– – ﹤0.01% 2479
2020
Q4 		$37K Hold
73
– – ﹤0.01% 2384
2020
Q3 		$19K Hold
73
– – ﹤0.01% 2456
2020
Q2 		$40K Buy
+73
New +$32.8K ﹤0.01% 2294

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canada Life's PASG Position: Q2 2022 in Review

Canada Life sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 113 shares — an estimated $8K sold.

Canada Life first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $40K in Q2 2020. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Canada Life reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 113 Passage Bio shares in Q2 2022, an estimated $8K.
  • Canada Life first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
  • Canada Life's Passage Bio position peaked at $40K in Q2 2020.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.